CompletedNot Applicable

Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance

United States2,140 participantsStarted 2011-01

Plain-language summary

This randomized controlled trial will compare strategies to reduce the risk of methicillin-resistant Staphylococcus aureus (MRSA) infection and re-hospitalization in MRSA carriers. This trial will provide critical answers about the role of decolonization versus standard-of-care education in preventing MRSA infections in the large group of high risk MRSA-positive patients being discharged from hospitals. Findings could potentially impact best practice for the 1.8 million MRSA carriers who are discharged from US hospitals each year.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 1\) At least 18 years old * 2\) Have had a positive culture (a type of test) for MRSA during recent hospital admission or within the 30 days prior to admission or following discharge * 3\) Able to give consent or have a primary caregiver provide consent * 4\) Able to bathe or shower or have this consistently performed by a willing caregiver Exclusion Criteria: * 1\) Known allergies to chlorhexidine or mupirocin

What they're measuring

Time to MRSA Infection

Timeframe: 1 year

Trial details

NCT IDNCT01209234

SponsorUniversity of California, Irvine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-01

Results submitted2019-08-12

View on ClinicalTrials.gov More Methicillin-resistant Staphylococcus Aureus trials